Novel fluoropyrimidine-based chemotherapy for advanced well-differentiated neuroendocrine tumors: a clinical update-Reference-Cited by-同舟云学术

Novel fluoropyrimidine-based chemotherapy for advanced well-differentiated neuroendocrine tumors: a clinical update

Published:2018-04-25 Issue:8 Volume:19 Page:795-807
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Zhang Heling¹,Shen Guoshuang¹,Zhang Shuisheng²,Du Feng³,Cao Yang⁴,Jiang Jun¹,Zheng Fangchao¹,Ma Xinfu¹,Wang Ziyi¹,Ren Dengfen¹,Ahmad Raees¹,Zhao Fuxin¹,Zhao Jiuda¹

Affiliation:

1. Affiliated Hospital of Qinghai University, Xining, China

2. Department of Medical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

3. Peking University Cancer Hospital and Institute, Beijing, China

4. The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

Funder

the first group of the Thousand Talents of Program of High-end Innovation of Qinghai Province in China

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2018.1465928

Reference94 articles.

1. Molecular Genetics of Gastroenteropancreatic Neuroendocrine Tumors

2. Gastroenteropancreatic neuroendocrine tumours

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of pathological stage and histological subtype on clinical outcome of adjuvant chemotherapy of paclitaxel plus carboplatin versus oral uracil–tegafur for non-small cell lung cancer: subanalysis of SLCG0401 trial;International Journal of Clinical Oncology;2019-07-16